Press Ctrl + D to add me to your bookmarks
Add to Google
Latest news headlines : China still lags behind in R&D and production of pharmaceutical excipients - Chinese Exports of western medicines see sustainable and high-speed growth in first half of 2008 - Chinese API manufacturers eying preparation market -
  Print

France's Saint-Gobain Investment in Changzhou Exceeds US$ 130 Million

By Saint Gobain, introduced by May Steed
Wednesday, 09 April 2008
We all know St-Gobain for its packaging applications serving the pharmaceutical industry. The group is now communicating an important investment in Changzhou, of more than US$ 130 Million.
As a global Fortune 500 company, France-based Saint-Gobain has quickened its deployment pace in China in the hope of riding the surging spree of China's robust economy.

On April 7th, senior corporate heads, including Raimund Heinl, president of Saint-Gobain TS (technical materials), Emmanuelle Picard, general manager for the Business Department of Grinding Wheel Mesh and for Strategic Development of Saint-Gobain TS, Eric Daniel, global technical supervisor for Saint-Gobain TS, and Fei Ming, general manager for the Asia-Pacific area of Saint-Gobain TS, visited the national new & high-tech zone in Changzhou, Jiangsu Province, where Saint-Gobain has injected a total investment of US$ 131.48 million, setting up three enterprises.

Yang Pingping and Dai Xiaowen, the director and the deputy director of the managing commission of Changzhou National High-tech District, met with the group of senior corporate heads. Yang Pingping said that the local government of Changzhou city will exert all its efforts to help the enterprises in Changzhou under the investment of Saint-Gobain develop a bigger and stronger presence in the new materials industry.
"Changzhou is a city full of vigor, where all the enterprises set up by Saint-Gobain gain a rapid development at present. This is inseparable from the support of the governments at both city and district levels. We are also very glad to further our business development in Changzhou," said Raimund Heinl.

Since 2004, Saint-Gobain has invested US$ 131.48 million in the Changzhou New & High-tech Zone, setting up, one after another, Saint-Gobain Technical Fabrics (Changzhou) Co., Ltd, Saint-Gobain Gypsum Building Materials (Changzhou) Co., Ltd., and Vetrotex Composite Material (Changzhou) Co., Ltd., with an accumulated registered capital of US$ 55.05 million.

In Feb. 2004, Saint-Gobain Vetrotex Group made a sole investment of US$ 29.98 million to set up, on its own, Saint-Gobain Technical Fabrics (Changzhou) Co., Ltd, the sales volume of which reached RMB 180 million in 2007.

At the end of 2005, Saint-Gobain purchased Jiahui Henghe Gypsum Building Materials (Changzhou) Co., Ltd. from BPB, after which the company changed its name to Saint-Gobain Gypsum Building Materials (Changzhou) Co., Ltd. with a total project investment of US$ 48.8 million and a registered capital of US$ 20 million. In June 2007, the company started its pilot production, yielding a sales volume of more than RMB 46 million in just half a year. In March 2008, Saint-Gobain finished its capital add-up concerning the Saint-Gobain plaster project in Changzhou, bringing the total investment and registered capital in
Changzhou respectively up to US$ 88.2 million and US$ 29.4 million.

In May 2007, Saint-Gobain established Vetrotex Composite Material (Changzhou) Co., Ltd., with a total investment of US$ 13.3 million and a registered capital of US$ 9.65 million. In 2007, the sales volume of the newly-established company reached RMB 170 million. As one of the world's top 100 industrial groups, Saint-Gobain ranked 116th in the global Fortune 500 list in 2007 and got first place in the category of building materials and glass. By the end of 2007, Saint-Gobain, with its 207,000-strong staff, realized a sales volume of EUR 43.4 billion.

"We enter China with strong momentum." According to the official website of Saint-Gobain (China) Investment Co., Ltd., the Asia-Pacific area, especially China, enjoys the quickest growth in the international business of Saint-Gobain, so the business lines of Saint-Gobain and its joint ventures in China are breeding new growth points.
Saint-Gobain is in an active gesture to gain the opportunity for its further development in China by launching its double programs concerning joint ventures and the newly-established companies.

The guideline of Saint-Gobain is to set up, in China, companies or branches under all of its affiliates and departments. Since its first entry into the Chinese market in 1985 until now, Saint-Gobain has established 46 enterprises or companies in China, with a recruitment of 11,700 employees at the end of 2007. The sales volume of Saint-Gobain in 2007 scored RMB 7.6 billion.
Latest News Headlines :
China still lags behind in R&D and production of pharmaceutical excipients
Chinese Exports of western medicines see sustainable and high-speed growth in first half of 2008
Chinese API manufacturers eying preparation market
Latest Press Releases Headlines :
Kowa Company, Ltd. Acquires ProEthic Pharmaceuticals, Inc.
Donation of Emergency Response Wireless Network (ERWN) equipment serves
China Biologic Products Announces Second Quarter 2008 Results Conference Call
Product of the month :
Advantia Coating Systems for pharmaceuticals
 
NEW! Send your Press Release for publication
Related Pharmaceutical & Lifesciences websites : Pharmaceutical Manufacturing News | Asia Lifesciences
Pharmaceutical packaging | APIs | Excipients | Generics | Processing | Outsourcing
QA/QC | Pharmaceutical Strategy | Drug Discovery | Biotechnology | Clincal Development
Subscribe Unsubscribe Advertise Privacy Statement Copyright
Intelligent Publishing MediaContact - 21, rue du Grand Prieuré – 75012 Paris FRANCE